A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers

Clinical trial NCT06013163 · UNKNOWN

Trial details

NCT number: NCT06013163
Sponsor: Empros Pharma AB
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight or Obesity

Start date: 2023-09-22
Primary completion: 2024-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.